Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (23)
Md. Mominur Rahman, Md. Rezaul Islam, Sadia Afsana Mim, Nasrin Sultana, Dinesh Kumar Chellappan, Kamal Dua, Mohammad Amjad Kamal, Rohit Sharma & Talha Bin Emran. (2022) Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation. Oxidative Medicine and Cellular Longevity 2022, pages 1-22.
Crossref
Crossref
Małgorzata Śmiarowska, Bogusław Brzuchalski, Elżbieta Grzywacz, Damian Malinowski, Anna Machoy-Mokrzyńska, Anna Pierzchlińska & Monika Białecka. (2022) Influence of COMT (rs4680) and DRD2 (rs1076560, rs1800497) Gene Polymorphisms on Safety and Efficacy of Methylphenidate Treatment in Children with Fetal Alcohol Spectrum Disorders. International Journal of Environmental Research and Public Health 19:8, pages 4479.
Crossref
Crossref
Judit Cabana-Domínguez, Bàrbara Torrico, Andreas Reif, Noèlia Fernàndez-Castillo & Bru Cormand. (2022) Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders. Translational Psychiatry 12:1.
Crossref
Crossref
Ziske Maritska, Fitri Fitri, BintangArroyantri Prananjaya, RadenAyu Mulya Liansari, Nita Parisa & MgsIrsan Saleh Hasani. (2022) DRD2 Gene-141C insertion/deletion polymorphism among schizophrenia patients: The first investigation in Palembang, Indonesia. Advances in Human Biology 12:3, pages 283.
Crossref
Crossref
G. Karacetin, B. Bayoglu, T. Eseroglu Soylemez, M. Topal, E. Bulanik Koc, M. Tekden, C. Ermis, T. Demir, M. Elagoz Yuksel, E.S. Ercan, M. Erkiran, S.B. Aksoyer Sezgin & M. Cengiz. (2022) BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders. The European Journal of Psychiatry 36:1, pages 26-34.
Crossref
Crossref
David P. Graham, Mark J. Harding & David A. Nielsen. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
437
490
.
Abinaya Chandrasekaran, Pia Jensen, Fadumo A. Mohamed, Madeline Lancaster, Michael E. Benros, Martin R. Larsen & Kristine K. Freude. (2021) A Protein-Centric View of in Vitro Biological Model Systems for Schizophrenia. Stem Cells 39:12, pages 1569-1578.
Crossref
Crossref
Parham Habibzadeh, Azim Nemati, Hassan Dastsooz, Afsaneh Taghipour‐Sheshdeh, Prisho Mariam Paul, Ali Sahraian & Mohammad Ali Faghihi. (2021) Investigating the association between common DRD2/ANKK1 genetic polymorphisms and schizophrenia: a meta-analysis. Journal of Genetics 100:2.
Crossref
Crossref
Kamila Kotowicz, Dorota Frydecka, Łukasz Gawęda, Katarzyna Prochwicz, Joanna Kłosowska, Joanna Rymaszewska, Agnieszka Samochowiec, Jerzy Samochowiec, Krzysztof Szczygieł, Edyta Pawlak‐Adamska, Elżbieta Szmida, Andrzej Cechnicki & Błażej Misiak. (2019) Effects of traumatic life events, cognitive biases and variation in dopaminergic genes on psychosis proneness. Early Intervention in Psychiatry 15:2, pages 248-255.
Crossref
Crossref
Anna Michalczyk, Justyna Pełka-Wysiecka, Jolanta Kucharska-Mazur, Michał Wroński, Błażej Misiak & Jerzy Samochowiec. (2020) Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia. Annals of General Psychiatry 19:1.
Crossref
Crossref
Yu Jiang, Baoying Liu, Chuancheng Wu, Xiaoyan Gao, Yaoqin Lu, Yulong Lian & Jiwen Liu. (2020) Dopamine Receptor D2 Gene (DRD2) Polymorphisms, Job Stress, and Their Interaction on Sleep Dysfunction. International Journal of Environmental Research and Public Health 17:21, pages 8174.
Crossref
Crossref
Md. Saddam Hussain, Shafayet Ahmed Siddiqui, Susmita Mondal, Md. Shalahuddin Millat, Sadiatul Marzan, Md. Giash Uddin, Md. Abdul Aziz, Md. Faruq Alam & Mohammad Safiqul Islam. (2020) Association of DRD2 gene polymorphisms with schizophrenia in the young Bangladeshi population: A pilot study. Heliyon 6:10, pages e05125.
Crossref
Crossref
Justin D. Tubbs, Jiahong Ding, Larry Baum & Pak C. Sham. (2020) Systemic neuro-dysregulation in depression: Evidence from genome-wide association. European Neuropsychopharmacology 39, pages 1-18.
Crossref
Crossref
Qurat‐ul‐Ain Amir, Farina Hanif, Washdev Washdev, Fareena Bilwani & Shabana Usman Simjee. (2020) Synonymous polymorphism rs201256011 in dopamine receptor type 2 gene is associated with schizophrenia and PANSS score in Pakistani population: A first report. International Journal of Clinical Practice 74:9.
Crossref
Crossref
Mansour Zamanpoor. (2020) Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. Psychiatric Genetics 30:1, pages 1-9.
Crossref
Crossref
Agata Faron-Górecka, Maciej Kuśmider, Joanna Solich, Andrzej Górecki & Marta Dziedzicka-Wasylewska. 2020. Oligomerization in Health and Disease: From Enzymes to G Protein-Coupled Receptors. Oligomerization in Health and Disease: From Enzymes to G Protein-Coupled Receptors
279
296
.
Yasuto Kunii, Mizuki Hino, Junya Matsumoto, Atsuko Nagaoka, Hiroyuki Nawa, Akiyoshi Kakita, Hiroyasu Akatsu, Yoshio Hashizume & Hirooki Yabe. (2019) Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder. Scientific Reports 9:1.
Crossref
Crossref
Yu Funahashi, Yuta Yoshino, Kiyohiro Yamazaki, Yuki Ozaki, Yoko Mori, Takaaki Mori, Shinichiro Ochi, Jun-ichi Iga & Shu-ichi Ueno. (2019) Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia. Psychiatry Research 278, pages 135-140.
Crossref
Crossref
Xi-cen Zhang, Mei Ding, Atif Adnan, Yi Liu, Yong-ping Liu, Jia-xin Xing, Jin-feng Xuan, Xi Xia, Jun Yao & Bao-jie Wang. (2019) No association between polymorphisms in the promoter region of dopamine receptor D2 gene and schizophrenia in the northern Chinese Han population: A case-control study. Brain and Behavior 9:2, pages e01193.
Crossref
Crossref
Sara Redenšek, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt & Vita Dolžan. (2019) Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Gurjit Kaur, Bir Singh Chavan, Deepti Gupta, Vikas Sinhmar, Rajendra Prasad, Adarsh Tripathi, P.D. Garg, Rajiv Gupta, Hitesh Khurana, Shiv Gautam, Mushtaq Ahmed Margoob & Jitender Aneja. (2019) An association study of dopaminergic (DRD2) and serotoninergic (5-HT2) gene polymorphism and schizophrenia in a North Indian population. Asian Journal of Psychiatry 39, pages 178-184.
Crossref
Crossref
Aya Matsusue & Shin-ichi Kubo. 2019. Forensic Medicine and Human Cell Research. Forensic Medicine and Human Cell Research
105
121
.
Aya Matsusue, Takaki Ishikawa, Tomoya Ikeda, Naoto Tani, Hisatomi Arima, Brian Waters, Kenji Hara, Masayuki Kashiwagi, Mio Takayama, Natsuki Ikematsu & Shin-ichi Kubo. (2018) DRD2/ANKK1 gene polymorphisms in forensic autopsies of methamphetamine intoxication fatalities. Legal Medicine 33, pages 6-9.
Crossref
Crossref